Furthermore, identification of microglial cytoprotective pathways for entities such as EPO and Wnt1 [59-61] may synergistically enhance the development of treatments for Alzheimer's disease. The gene discussed is WNT1; the disease is early-onset autosomal dominant Alzheimer disease.